Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
David Loebenberg
Observed names:
D Loebenberg,
D. LOEBENBERG,
D. Loebenberg,
DAVID LOEBENBERG,
Loebenberg, David
Observed institutions:
Merck & Co., Inc., Rahway, NJ, USA (United States),
The University of Texas at San Antonio Health Science Center,
Universidad de Buenos Aires,
Biological E (India),
National Cancer Institute
OpenAlex ID:
A5006351069
Nonfilamentous C. albicans Mutants Are Avirulent
1997
·
Hsiu-Jung Lo
, Julia R Köhler
, et al.
·
Cell
·
1,809
PDF
In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts
2006
·
F. Sabatelli
, R. Patel
, et al.
·
Antimicrobial Agents and Chemotherapy
·
491
Three-Dimensional Models of Wild-Type and Mutated Forms of Cytochrome P450 14α-Sterol Demethylases from Aspergillus fumigatus and Candida albicans Provide Insights into Posaconazole Binding
2004
·
Li Xiao
, Vincent Madison
, et al.
·
Antimicrobial Agents and Chemotherapy
·
266
Mutations in Aspergillus fumigatus Resulting in Reduced Susceptibility to Posaconazole Appear To Be Restricted to a Single Amino Acid in the Cytochrome P450 14α-Demethylase
2003
·
Paul A. Mann
, Raulo M. Parmegiani
, et al.
·
Antimicrobial Agents and Chemotherapy
·
188
Application of Real-Time Quantitative PCR to Molecular Analysis of Candida albicans Strains Exhibiting Reduced Susceptibility to Azoles
2004
·
Andrew S. Chau
, Cara A. Mendrick
, et al.
·
Antimicrobial Agents and Chemotherapy
·
187
Activities of the Triazole Derivative SCH 56592 (Posaconazole) against Drug-Resistant Strains of the Protozoan Parasite Trypanosoma ( Schizotrypanum ) cruzi in Immunocompetent and Immunosuppressed Murine Hosts
2000
·
Judith Molina
, Olindo Martins-Filho
, et al.
·
Antimicrobial Agents and Chemotherapy
·
185
In Vivo Activity of Posaconazole againstMucorspp. in an Immunosuppressed-Mouse Model
2002
·
Qiu N. Sun
, Laura K. Najvar
, et al.
·
Antimicrobial Agents and Chemotherapy
·
184
Pharmacodynamics of a New Triazole, Posaconazole, in a Murine Model of Disseminated Candidiasis
2003
·
D. Andes
, K. Marchillo
, et al.
·
Antimicrobial Agents and Chemotherapy
·
177
Antiproliferative Effects and Mechanism of Action of SCH 56592 against Trypanosoma ( Schizotrypanum ) cruzi : In Vitro and In Vivo Studies
1998
·
Julio A. Urbina
, Gilberto Payares
, et al.
·
Antimicrobial Agents and Chemotherapy
·
162
PDF
Activity of Posaconazole in Treatment of Experimental Disseminated Zygomycosis
2003
·
Eric Dannaoui
, Jacques F. G. M. Meis
, et al.
·
Antimicrobial Agents and Chemotherapy
·
159
Comparison of Pathogenesis and Host Immune Responses toCandida glabrataandCandida albicansin Systemically Infected Immunocompetent Mice
2001
·
Joan Brieland
, David Essig
, et al.
·
Infection and Immunity
·
117
In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against Aspergillus and Candida
2000
·
Anthony Cacciapuoti
, David Loebenberg
, et al.
·
Antimicrobial Agents and Chemotherapy
·
110
Cytokine Networking in Lungs of Immunocompetent Mice in Response to Inhaled Aspergillus fumigatus
2001
·
Joan K. Brieland
, Craig Jackson
, et al.
·
Infection and Immunity
·
104
In vitroactivities of new and established triazoles against opportunistic filamentous and dimorphic fungi
2005
·
Gloria M. González
, Annette W. Fothergill
, et al.
·
Medical Mycology
·
103
Granulocyte Colony-Stimulating Factor and Azole Antifungal Therapy in Murine Aspergillosis: Role of Immune Suppression
1998
·
John R. Graybill
, Rosie Bocanegra
, et al.
·
Antimicrobial Agents and Chemotherapy
·
89
PDF
Kijanimicin (Sch 25663), a novel antibiotic produced by Actionmadura kijaniata SCC 1256. Fermentation, isolation, characterization and biological properties.
1981
·
J. ALLAN WAITZ
, ANN C. HORAN
, et al.
·
The Journal of Antibiotics
·
83
PDF
Posaconazole Is a Potent Inhibitor of Sterol 14α-Demethylation in Yeasts and Molds
2004
·
Hanan K. Munayyer
, Paul A. Mann
, et al.
·
Antimicrobial Agents and Chemotherapy
·
79
Comparison of a New Triazole Antifungal Agent, Schering 56592, with Itraconazole and Amphotericin B for Treatment of Histoplasmosis in Immunocompetent Mice
1999
·
Patricia Connolly
, Joe Wheat
, et al.
·
Antimicrobial Agents and Chemotherapy
·
75
PDF
Efficacy of the Triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous and Visceral Leishmaniases
1999
·
Hail M. Al-Abdely
, John R. Graybill
, et al.
·
Antimicrobial Agents and Chemotherapy
·
73
PDF
Pharmacokinetics of SCH 56592, a New Azole Broad-Spectrum Antifungal Agent, in Mice, Rats, Rabbits, Dogs, and Cynomolgus Monkeys
2000
·
Amin A. Nomeir
, Pramila Kumari
, et al.
·
Antimicrobial Agents and Chemotherapy
·
72
Treatment of Murine Fusariosis with SCH 56592
1999
·
M. Lozano-Chiu
, S. Arikan
, et al.
·
Antimicrobial Agents and Chemotherapy
·
72
PDF
Comparison of a New Triazole, Posaconazole, with Itraconazole and Amphotericin B for Treatment of Histoplasmosis following Pulmonary Challenge in Immunocompromised Mice
2000
·
Patricia Connolly
, L. Joseph Wheat
, et al.
·
Antimicrobial Agents and Chemotherapy
·
70
In Vitro and In Vivo Activities of Posaconazole against Coccidioides immitis
2002
·
Gloria M. González
, Rolando Tijerina
, et al.
·
Antimicrobial Agents and Chemotherapy
·
69
Efficacy of SCH56592 in a Rabbit Model of Invasive Aspergillosis
2000
·
William R. Kirkpatrick
, Robert K. McAtee
, et al.
·
Antimicrobial Agents and Chemotherapy
·
64
SCH 56592, Amphotericin B, or Itraconazole Therapy of Experimental Murine Cerebral Phaeohyphomycosis Due to Ramichloridium obovoideum (“ Ramichloridium mackenziei ”)
2000
·
Hail M. Al-Abdely
, Laura Najvar
, et al.
·
Antimicrobial Agents and Chemotherapy
·
58
Show more works
View as search
Works count:
159
Citation count:
6,614
H-index:
35
I10-index:
84
Year
Topic
Type